| Erin Mcelroy, | |
|
9458 Helena Rd, Pelham, AL 35124-2743 | |
| (205) 444-9488 | |
| (205) 989-8478 |
| Full Name | Erin Mcelroy |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 9458 Helena Rd, Pelham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184973463 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 10368 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Erin Mcelroy, 9458 Helena Rd, Pelham, AL 35124-2743 Ph: (205) 444-9488 | Erin Mcelroy, 9458 Helena Rd, Pelham, AL 35124-2743 Ph: (205) 444-9488 |
News Archive
"In one of the most significant victories for public health policy, the Australian High Court upheld the Tobacco Plain Packaging Act, which effectively removes the last form of advertising available to the tobacco industry in the country - logos on cigarette packs," Cynthia Lewis, a senior program officer for the tobacco initiative at the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog.
The National Comprehensive Cancer Network Oncology Research Program (ORP) has been awarded a $2 million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to develop a program to scientifically evaluate and define the clinical effectiveness of Afatinib (BIBW 2992) in solid tumors, including breast, head and neck, and non-small cell lung (NSCL) cancers.
With around 30 percent of the U.S. population now fully vaccinated, the rate of daily vaccinations has started to slow, raising concerns that greater efforts and investments may be needed to reach higher coverage levels.
Sonomax Hearing Healthcare Inc. is pleased to announce that it has entered into an agreement with Benvest New Look Income Fund, a Québec-based income trust, that will provide gross proceeds to Sonomax of approximately $1.74 million in non-dilutive capital, concurrent with a corporate reorganization of Sonomax.
Cell Therapeutics, Inc. (CTI) announced today that on February 9, 2012 the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) will review CTI's resubmitted New Drug Application (NDA) for pixantrone for the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL) in patients who failed two or more lines of prior therapy.
› Verified 5 days ago
Neil Damron, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1573 Cahaba Valley Rd, Pelham, AL 35124 Phone: 205-988-5023 Fax: 205-988-5024 | |
Mrs. Julia B Brackeen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 365 Huntley Pkwy, Pelham, AL 35124 Phone: 205-620-0691 Fax: 205-620-0919 | |
Dr. Charles Phillip Lawrence, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9458 Helena Rd, Pelham, AL 35124 Phone: 205-444-9488 Fax: 205-989-8478 | |
Christie Ellison Huner, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3340 Pelham Pkwy, Pelham, AL 35124 Phone: 205-664-8027 Fax: 205-664-8312 | |
Darrelle Knight Marbury, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 563 Cahaba Manor Dr, Pelham, AL 35124 Phone: 504-250-7418 | |
Ashley Stokes, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9458 Helena Rd, Pelham, AL 35124 Phone: 205-444-9488 | |
Colleen Casey Odonnell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2181 Pelham Pkwy, Pelham, AL 35124 Phone: 205-987-0301 |